BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21598625)

  • 1. [In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v].
    Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Mazurkova NA; Sergeev AA; Serova OA; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):93-6. PubMed ID: 21598625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro efficacy of Ingavirin against the pandemic influenza virus A(H1N1/09)v].
    Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Erdyneeva UB; Mazurkova NA; Serova OA; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(3-4):12-6. PubMed ID: 20695202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
    Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
    Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)].
    Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Nebol'sin VE
    Antibiot Khimioter; 2008; 53(7-8):27-30. PubMed ID: 19227120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiviral effect of Ingavirin against seasonal influenza virus A/H1N1 in MDCK cell culture].
    Galegov GA; Andronova VL; Nebol'sin VE
    Antibiot Khimioter; 2009; 54(9-10):19-22. PubMed ID: 20415258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of Ingavirin against influenza virus A (H3N2)].
    Loginova SIa; Borisevich SV; Semenova IV; Maksimov VA; Bondarev VP; Nebol'sin VE
    Antibiot Khimioter; 2009; 54(9-10):23-6. PubMed ID: 20415259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro efficacy of ingavirin against the Mexican pandemic subtype H1N1 of influenza A virus, strains A/California/04/2009 and A/California/07/2009].
    Loginova SIa; Borisevich SV; Lykov MV; Vedenina EV; Borisevich GV; Bondarev VP; Nebol'sin VE; Chuchalin AG
    Antibiot Khimioter; 2009; 54(3-4):15-7. PubMed ID: 19711843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of prophylactic activity of Ingavirin, a new Russian drug, against grippe A virus (H3N2)].
    Loginova SIa; Borisevich SV; Maksimov VA; Bondarev VP; Nebol'sin VE
    Antibiot Khimioter; 2008; 53(11-12):19-21. PubMed ID: 19441652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
    Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
    Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of Ingavirin antiviral activity against Mexican pandemic influenza virus A/H1N1/2009 in vitro and in vivo].
    Loginova SY; Borisevich SV; Shchukina VN; Lykov MV; Borisevich GV; Bondarev VP; Nebolsin VE; Sutochnikova OA; Chychalin AG
    Antibiot Khimioter; 2010; 55(11-12):17-21. PubMed ID: 21574420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pandemic influenza in Russia: specific features of clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease].
    Kolobukhina LV; Merkulova LN; Shchelkanov MIu; Burtseva EI; Lavrishcheva VV; Samokhvalov EI; Al'khovskiĭ SV; Prilipov AG; Proshina ES; Avdeev SN; Sutochnikova OA; Bazarova MV; Kelli EI; Tserukalova ND; Blank IA; Shestakova OM; Kolivashko ON; Arseneva TV; Ambrosi OE; Shul'diakov AA; Popov AF; Simakova AI; Malyshev NA; Chuchalin AG; L'vov DK
    Ter Arkh; 2011; 83(9):48-53. PubMed ID: 22145388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice].
    Zarubaev VV; Garshinina AV; Kalinina NA; Shtro AA; Beliaevskaia SV; Nebol'sin VE; Kiselev OI
    Antibiot Khimioter; 2010; 55(5-6):24-31. PubMed ID: 21033471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)].
    Loginova SIa; Borisevich SV; Shkliaeva OM; Maksimov VA; Bondarev VP; Nebol'sin VE
    Antibiot Khimioter; 2010; 55(7-8):10-2. PubMed ID: 21140557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].
    Fediakina IT; Shchelkanov MIu; Deriabin PG; Leneva IA; Gudova NV; Kondrat'eva TV; L'vov DK
    Antibiot Khimioter; 2011; 56(3-4):3-9. PubMed ID: 21913403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.
    Liu Z; Guo Z; Wang G; Zhang D; He H; Li G; Liu Y; Higgins D; Walsh A; Shanahan-Prendergast L; Lu J
    Eur J Pharm Sci; 2009 Oct; 38(3):215-23. PubMed ID: 19616097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
    Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
    Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
    Sriwilaijaroen N; Wilairat P; Hiramatsu H; Takahashi T; Suzuki T; Ito M; Ito Y; Tashiro M; Suzuki Y
    Virol J; 2009 Aug; 6():124. PubMed ID: 19678928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.